News & Updates
Filter by Specialty:
Psychedelic drugs show promise for anxiety, depression
Use of psychedelic drugs appears to have some benefits in reducing anxiety and depressive symptoms among patients with cancer or other life-threatening diseases, reports a study.
Psychedelic drugs show promise for anxiety, depression
08 Jun 2023
Attention bias modification treatment eases symptoms in social anxiety disorder
People with social anxiety disorder (SAD) may benefit from gaze-contingent music reward therapy (GC-MRT), an eye-tracking-based attention bias modification treatment, which has been shown to reduce SAD symptoms in a recent study.
Attention bias modification treatment eases symptoms in social anxiety disorder
01 Jun 2023
Genetically predicted depression linked to multiple gastrointestinal disorders
Genetic predisposition to major depressive disorder has the potential to increase the risk of gastrointestinal disorders such as gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), peptic ulcer disease, and nonalcoholic fatty liver disease (NAFLD), according to the results of a Mendelian randomization study.
Genetically predicted depression linked to multiple gastrointestinal disorders
31 May 2023
COVID-19 vaccine boosters effective against Omicron in people with substance use disorder
COVID-19 vaccine boosters provide protection against Omicron infection and related hospitalization among people with substance use disorder, researchers from the University of Hong Kong have reported.
COVID-19 vaccine boosters effective against Omicron in people with substance use disorder
29 May 2023
In-utero exposure to poor air quality a risk factor for childhood ADHD
Children born to mothers who were exposed to polluted air while pregnant are at increased risk of childhood attention-deficit hyperactivity disorder (ADHD), according to a study presented at PAS 2023.